XNAS · GLMD
-6.68% · -$0.0381 · Vol 25.4K
Market closed · last close 4:00 PM ET · price as of 16:28:32 ET
Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd.

$0.5319
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
HISTORY WINDOW BUILDING
AI Analysis
Sovereign

Why is GLMD moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for GLMD are being assembled.
About Galmed Pharmaceuticals Ltd.
Listed since
2014
Employees
6
Country
US

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.5590
Day high
$0.5700
Day low
$0.5420
Previous close
$0.5700
52W high
$0.5700
-6.68% from high
52W low
$0.5319
0% of range
Market cap
$4.4M
Shares out
7.7M
Volume
25.4K
VWAP
$0.5482
Price history computed in-house
SMA 50 $0.5370 · below
SMA 200 $0.5370 · below
52W position 0%
Veridion warehouse edge

Warehouse intelligence for GLMD.

Veridion Score
19
0: Not reported1: 312: 323: Not reported4: Not reported5: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

GLMD insider activity

Galmed Pharmaceuticals Ltd.

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for GLMD.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

GLMD contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for GLMD in this window.
Lobbying spend

GLMD lobbying filings, year to date.

Registered lobbying filings matched to Galmed Pharmaceuticals Ltd..

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for GLMD in this window.
Latest news · GLMD
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for GLMD.
Options
Sovereign unlock shows live options positioning for GLMD.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.